| Price | Rs 935.19 |
| ZEME fair value | Rs 1,000.91 |
| Discount to fair value | 7.0% |
| Smart-money phase | Fully Loaded |
| Confidence score | 50/100 |
| RSI (14) | 45.5 |
| P/E | 11.0 |
| ROE | —% |
| Dividend yield | 4.2% |
| 52-week range | Rs 836.92 – Rs 1,299.46 |
| Sector | Pharmaceuticals |
| Shariah-compliant | Yes ☪ |
ABOT (Abbott Laboratories Pakistan Limited) trades at Rs 935.19 on the Pakistan Stock Exchange, in the Fully Loaded smart-money phase — accumulated. ZEME's model puts fair value near Rs 1,000.91, making it about 7.0% undervalued. Smart money has fully loaded the position — a mature bullish setup, often before a markup.
ZEME AI reads ABOT through operator accumulation/distribution phases, fair value across three methods, RSI and volume, plus institutional flow (FIPI/LIPI & off-market) — the same smart-money engine behind our daily PSX signals. For the live chart, entry/stop/target and history, open the interactive analysis above.
Yes — on ZEME's read, it shows smart-money accumulation AND trades below fair value. Smart money has fully loaded the position — a mature bullish setup, often before a markup. As of 20 Jul 2026, ABOT is in the Fully Loaded phase with a ZEME confidence score of 50/100.
ZEME estimates ABOT's fair value at about Rs 1,000.91, versus a market price of Rs 935.19 — roughly 7.0% undervalued.
ABOT is currently in the Fully Loaded phase. Smart money has fully loaded the position — a mature bullish setup, often before a markup.
Data updated 20 Jul 2026 from ZEME AI's PSX engine. Educational analytics, not investment advice — do your own research and use a stop loss. Trading carries risk.